Compare Stocks › ABBV vs CB

AbbVie Inc. (ABBV) vs Chubb Limited (CB): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. CB is fairly valued at $364, with an intrinsic value of $366 and a margin of safety of 1%. Of the two, CB has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
CB
Chubb Limited
$364.12

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CB
  • ★Chubb Limited scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Each dollar of retained earnings has created $2.32 of earning power — management is an exceptional capital allocator.
  • ★FCF yield of 8.1% is historically attractive — the business generates significant cash relative to its price.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
CB
  • ⚠PEG ratio of 2.74 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠Altman Z-Score of 0.96 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠Insiders have sold $6.7M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
ABBV
CB
Valuation
N/A
Free Cash Flow
$11.23B
N/A
FCF Yield
8.08%
50.67
Trailing P/E
12.76
18.24
Forward P/E
12.36
Quality & Moat
29.08%
ROIC
9.62%
N/A
ROE
14.25%
73.72%
Gross Margin
29.80%
0.60
PEG Ratio
2.74
Balance Sheet Safety
N/A
Net Debt / Equity
0.23
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.27
2.35%
Dividend Yield
1.12%
ABBV: 4Ties: 1CB: 3
ABBVCB

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CB

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CB
$1.26
created per $1 retained over 3 years
Value Creator
Σ Retained
$24.27B
Δ Market Cap
+$30.61B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CB
0.6% Margin of Safety
Price is 0.6% below estimated fair value
Current Price: $364.12
Fair Value: $366.48
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

CB

What growth rate is the market pricing in at $364?

+4.0%
Market-Implied Owner Earnings Growth
Standard FCF implies +2.8%

The market implies +4.0% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +2.8%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CB
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CB
-2.47
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CB
Insiders 9.5%Institutions 85.0%Retail & Other 5.5%
No. of Institutional Holders2,790
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CB
0
Buys (3M)
0
Buys (12M)
CORBAT MICHAEL L
Director
$114,665
@ $269.80 · 2025-07-25
KEOGH JOHN W
President
$2.87M
@ $293.01 · 2025-06-06
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CB
2
Sells (3M)
18
Sells (12M)
Total value (12M): $51.70M
BOROUGHS TIMOTHY ALAN
Chief Investment Officer
$4.85M
@ $356.77 · 2026-10-26
CONNORS MICHAEL P
Director
$1.90M
@ $345.00 · 2026-08-21
WAYLAND JOSEPH F
General Counsel
$3.10M
@ $364.54 · 2026-07-28
ORTEGA JUAN LUIS
Officer
$1.25M
@ $322.08 · 2026-06-08
KEOGH JOHN W
President
$7.39M
@ $321.51 · 2026-05-27
ATIEH MICHAEL G
Director
$190,468
@ $329.53 · 2026-05-21
STEIMER OLIVIER
Director
$658,600
@ $329.30 · 2026-03-19
OHSIEK GEORGE F
Officer
$250,408
@ $325.21 · 2026-03-06
JOHNS BRYCE L
Officer
$504,925
@ $336.62 · 2026-03-04
WAYLAND JOSEPH F
General Counsel
$2.57M
@ $336.44 · 2026-03-03
OHSIEK GEORGE F
Officer
$1.67M
@ $325.43 · 2026-02-13
GREENBERG EVAN G
Chief Executive Officer
$5.00M
@ $335.09 · 2026-02-12
BOROUGHS TIMOTHY ALAN
Chief Investment Officer
$9.23M
@ $331.98 · 2026-02-06
GREENBERG EVAN G
Chief Executive Officer
$4.99M
@ $331.47 · 2026-02-05
ORTEGA JUAN LUIS
Officer
$1.29M
@ $295.04 · 2025-12-02
ORTEGA JUAN LUIS
Officer
$253,666
@ $293.59 · 2025-12-02
LUPICA JOHN J
Officer
$4.85M
@ $296.45 · 2025-11-14
WAYLAND JOSEPH F
General Counsel
$1.73M
@ $297.08 · 2025-11-13
LUPICA JOHN J
Officer
$6.66M
@ $281.00 · 2025-10-27
LUPICA JOHN J
Officer
$1.60M
@ $290.06 · 2025-07-01
ATIEH MICHAEL G
Director
$154,707
@ $287.56 · 2025-06-16
WAYLAND JOSEPH F
General Counsel
$1.54M
@ $293.16 · 2025-06-04
KEOGH JOHN W
President
$24.69M
@ $290.24 · 2025-05-21
ORTEGA JUAN LUIS
Officer
$1.90M
@ $292.13 · 2025-05-20
WAYLAND JOSEPH F
General Counsel
$3.61M
@ $294.82 · 2025-03-20
BOROUGHS TIMOTHY ALAN
Officer
$4.37M
@ $296.12 · 2025-03-18
OHSIEK GEORGE F
Officer
$221,583
@ $290.41 · 2025-03-14
WAYLAND JOSEPH F
General Counsel
$2.87M
@ $286.96 · 2025-03-04
OHSIEK GEORGE F
Officer
$269,503
@ $267.63 · 2025-02-11
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CB
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
CB
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
View ABBV Full AnalysisView CB Full Analysis

Frequently Asked Questions: ABBV vs CB

Is AbbVie Inc. or Chubb Limited more undervalued in 2026?▼

Based on our discounted cash flow model, CB trades at a 0.6% margin of safety (intrinsic value $366 vs. price $364), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Chubb Limited?▼

CB scores 100/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Chubb Limited in financial distress?▼

CB's Altman Z-Score of 1.0 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Chubb Limited?▼

ABBV earns 29.1% ROIC versus CB's 9.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Chubb Limited's?▼

CB's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). CB has raised its dividend for 3 consecutive years.

ABBV vs CB: Which Is the Better Buy in 2026? | SafetyMargin.io